speb/financial-data huggingface dataset:
URGN balance_sheet (annual, 2023-12-31) — Long Term Debt: 98551000.00
URGN balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 99395000.00
URGN cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 0.00
URGN balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 2905000.00
URGN cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 67358000.00
URGN balance_sheet (annual, 2023-12-31) — Net Debt: 3549000.00
URGN income_statement (annual, 2023-12-31) — Net Income: -102244000.00
URGN income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -102244000.00
URGN income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -102244000.00
URGN income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -102244000.00
URGN income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -102244000.00
URGN cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -102244000.00
URGN income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -102244000.00
URGN income_statement (annual, 2023-12-31) — Net Interest Income: -33626000.00
URGN cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -759000.00
URGN cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 0.00
URGN cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 0.00
URGN income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -33626000.00
URGN balance_sheet (annual, 2023-12-31) — Net PPE: 2360000.00
URGN cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -194000.00
URGN balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -65212000.00
URGN income_statement (annual, 2023-12-31) — Normalized EBITDA: -81904000.00
URGN income_statement (annual, 2023-12-31) — Normalized Income: -102244000.00
URGN cash_flow (annual, 2023-12-31) — Operating Cash Flow: -76376000.00
URGN cash_flow (annual, 2023-12-31) — Operating Gains Losses: 11504000.00
URGN income_statement (annual, 2023-12-31) — Operating Income: -65536000.00
URGN income_statement (annual, 2023-12-31) — Operating Revenue: 82713000.00
URGN balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 32490119.00
URGN balance_sheet (annual, 2023-12-31) — Other Current Assets: 10281000.00
URGN balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 3860000.00
URGN balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: 12000.00
URGN income_statement (annual, 2023-12-31) — Other Income Expense: 838000.00
URGN balance_sheet (annual, 2023-12-31) — Other Inventories: 32000.00
URGN cash_flow (annual, 2023-12-31) — Other Non Cash Items: 1014000.00
URGN balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 2263000.00
URGN income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 838000.00
URGN balance_sheet (annual, 2023-12-31) — Other Properties: 2790000.00
URGN balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 41966000.00
URGN balance_sheet (annual, 2023-12-31) — Payables: 6514000.00
URGN balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 16538000.00
URGN balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 10814000.00
URGN income_statement (annual, 2023-12-31) — Pretax Income: -98324000.00
URGN cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 49573000.00
URGN balance_sheet (annual, 2023-12-31) — Properties: 0.00
URGN cash_flow (annual, 2023-12-31) — Purchase Of Investment: -49832000.00
URGN cash_flow (annual, 2023-12-31) — Purchase Of PPE: -194000.00
URGN balance_sheet (annual, 2023-12-31) — Raw Materials: 2764000.00
URGN balance_sheet (annual, 2023-12-31) — Receivables: 15443000.00
URGN income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 9361000.00
URGN income_statement (annual, 2023-12-31) — Reconciled Depreciation: 1705000.00
URGN income_statement (annual, 2023-12-31) — Research And Development: 45614000.00
URGN balance_sheet (annual, 2023-12-31) — Restricted Cash: 821000.00
URGN balance_sheet (annual, 2023-12-31) — Retained Earnings: -679348000.00
URGN cash_flow (annual, 2023-12-31) — Sale Of Investment: 49073000.00
URGN income_statement (annual, 2023-12-31) — Selling General And Administration: 93274000.00
URGN balance_sheet (annual, 2023-12-31) — Share Issued: 32490119.00
URGN cash_flow (annual, 2023-12-31) — Stock Based Compensation: 9343000.00
URGN balance_sheet (annual, 2023-12-31) — Stockholders Equity: -65212000.00
URGN balance_sheet (annual, 2023-12-31) — Tangible Book Value: -65212000.00
URGN income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
URGN income_statement (annual, 2023-12-31) — Tax Provision: 3920000.00
URGN income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.21
URGN balance_sheet (annual, 2023-12-31) — Total Assets: 178311000.00
URGN balance_sheet (annual, 2023-12-31) — Total Capitalization: 33339000.00
URGN balance_sheet (annual, 2023-12-31) — Total Debt: 99395000.00
URGN balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: -65212000.00
URGN income_statement (annual, 2023-12-31) — Total Expenses: 148249000.00
URGN balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 243523000.00
URGN balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 9125000.00
URGN balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 212311000.00
URGN income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -65536000.00
URGN income_statement (annual, 2023-12-31) — Total Other Finance Cost: 21552000.00
URGN income_statement (annual, 2023-12-31) — Total Unusual Items: -21552000.00
URGN income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -21552000.00
URGN balance_sheet (annual, 2023-12-31) — Tradeand Other Payables Non Current: 3194000.00
URGN balance_sheet (annual, 2023-12-31) — Working Capital: 137974000.00
URGN balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 4641000.00
URGN cash_flow (quarterly, 2024-09-30) — Change In Other Working Capital: 0.00
URGN income_statement (quarterly, 2024-09-30) — Gain On Sale Of Security: -5915000.00
URGN income_statement (quarterly, 2024-09-30) — Total Unusual Items: -5915000.00
URGN income_statement (quarterly, 2024-09-30) — Total Unusual Items Excluding Goodwill: -5915000.00
URGN income_statement (annual, 2024-12-31) — +Operating Expense: 178299000.00
URGN income_statement (annual, 2024-12-31) — +Total Revenue: 90398000.00
URGN balance_sheet (annual, 2024-12-31) — Accounts Payable: 10931000.00
URGN balance_sheet (annual, 2024-12-31) — Accounts Receivable: 20302000.00
URGN balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -4281000.00
URGN balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 797248000.00
URGN cash_flow (annual, 2024-12-31) — Amortization Of Securities: -2891000.00
URGN balance_sheet (annual, 2024-12-31) — Available For Sale Securities: 5022000.00
URGN balance_sheet (quarterly, 2024-12-31) — Available For Sale Securities: 5022000.00
URGN income_statement (annual, 2024-12-31) — Basic Average Shares: 42876737.00
URGN income_statement (annual, 2024-12-31) — Basic EPS: -2.96
URGN cash_flow (annual, 2024-12-31) — Beginning Cash Position: 95823000.00
URGN cash_flow (annual, 2024-12-31) — Capital Expenditure: -295000.00
URGN balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 1653000.00
URGN balance_sheet (annual, 2024-12-31) — Capital Stock: 115000.00
URGN balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 171987000.00
URGN balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 236685000.00
URGN cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 194619000.00
URGN cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -20613000.00
URGN cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -96766000.00
URGN cash_flow (annual, 2024-12-31) — Change In Account Payable: 10893000.00
URGN cash_flow (annual, 2024-12-31) — Change In Accrued Expense: -244000.00
URGN cash_flow (annual, 2024-12-31) — Change In Inventory: -3554000.00
URGN cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 1449000.00
URGN cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -237000.00
URGN cash_flow (annual, 2024-12-31) — Change In Other Working Capital: 49000.00
URGN cash_flow (quarterly, 2024-12-31) — Change In Other Working Capital: -1000.00
URGN cash_flow (annual, 2024-12-31) — Change In Payable: 10893000.00
URGN cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 10649000.00
URGN cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 1436000.00
URGN cash_flow (annual, 2024-12-31) — Change In Receivables: -4859000.00
URGN cash_flow (annual, 2024-12-31) — Change In Working Capital: 4933000.00
URGN cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -4859000.00
URGN cash_flow (annual, 2024-12-31) — Changes In Cash: 77240000.00
URGN balance_sheet (annual, 2024-12-31) — Common Stock: 115000.00
URGN balance_sheet (annual, 2024-12-31) — Common Stock Equity: -8803000.00
URGN cash_flow (annual, 2024-12-31) — Common Stock Issuance: 151169000.00
URGN income_statement (annual, 2024-12-31) — Cost Of Revenue: 8881000.00
URGN balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 16500000.00
URGN balance_sheet (annual, 2024-12-31) — Current Assets: 276135000.00
URGN balance_sheet (annual, 2024-12-31) — Current Liabilities: 45949000.00
URGN cash_flow (annual, 2024-12-31) — Depreciation: 1186000.00
URGN cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 1186000.00
URGN cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 1186000.00
URGN balance_sheet (annual, 2024-12-31) — Derivative Product Liabilities: 121387000.00
URGN income_statement (annual, 2024-12-31) — Diluted Average Shares: 42876737.00
URGN income_statement (annual, 2024-12-31) — Diluted EPS: -2.96
URGN income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -126874000.00
URGN income_statement (annual, 2024-12-31) — EBIT: -111521000.00
URGN income_statement (annual, 2024-12-31) — EBITDA: -110335000.00
URGN cash_flow (annual, 2024-12-31) — End Cash Position: 173063000.00
URGN cash_flow (annual, 2024-12-31) — Financing Cash Flow: 194619000.00
URGN balance_sheet (annual, 2024-12-31) — Finished Goods: 4522000.00
URGN cash_flow (annual, 2024-12-31) — Free Cash Flow: -97061000.00
URGN cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 15077000.00
URGN income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -23411000.00
URGN income_statement (quarterly, 2024-12-31) — Gain On Sale Of Security: -6063000.00
URGN balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 56000.00
URGN balance_sheet (annual, 2024-12-31) — Gross PPE: 8070000.00
URGN income_statement (annual, 2024-12-31) — Gross Profit: 81517000.00
URGN income_statement (annual, 2024-12-31) — Interest Expense: 12521000.00
URGN income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 12521000.00
URGN income_statement (annual, 2024-12-31) — Interest Income: 8901000.00
URGN income_statement (annual, 2024-12-31) — Interest Income Non Operating: 8901000.00
URGN balance_sheet (annual, 2024-12-31) — Inventory: 9227000.00
URGN balance_sheet (annual, 2024-12-31) — Invested Capital: 112931000.00
URGN cash_flow (annual, 2024-12-31) — Investing Cash Flow: -20613000.00
URGN balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 5022000.00
URGN balance_sheet (quarterly, 2024-12-31) — Investmentin Financial Assets: 5022000.00
URGN balance_sheet (annual, 2024-12-31) — Investments And Advances: 5022000.00
URGN balance_sheet (quarterly, 2024-12-31) — Investments And Advances: 5022000.00
URGN cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 151169000.00
URGN cash_flow (annual, 2024-12-31) — Issuance Of Debt: 24488000.00
URGN cash_flow (quarterly, 2024-12-31) — Issuance Of Debt: 0.00
URGN balance_sheet (annual, 2024-12-31) — Leases: 626000.00
URGN balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 1653000.00
URGN balance_sheet (annual, 2024-12-31) — Long Term Debt: 121734000.00
URGN balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 123387000.00
URGN cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 24488000.00
URGN cash_flow (quarterly, 2024-12-31) — Long Term Debt Issuance: 0.00
URGN cash_flow (annual, 2024-12-31) — Long Term Debt Payments: 0.00
URGN balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 3154000.00
URGN cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 151169000.00
URGN income_statement (annual, 2024-12-31) — Net Income: -126874000.00
URGN income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -126874000.00
URGN income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -126874000.00
URGN income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -126874000.00
URGN income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -126874000.00
URGN cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -126874000.00
URGN income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -126874000.00
URGN income_statement (annual, 2024-12-31) — Net Interest Income: -27031000.00
URGN cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -20318000.00
URGN cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 24488000.00
URGN cash_flow (quarterly, 2024-12-31) — Net Issuance Payments Of Debt: 0.00
URGN cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 24488000.00
URGN cash_flow (quarterly, 2024-12-31) — Net Long Term Debt Issuance: 0.00
URGN income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -27031000.00
URGN balance_sheet (annual, 2024-12-31) — Net PPE: 3789000.00
URGN cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -295000.00
URGN balance_sheet (annual, 2024-12-31) — Net Tangible Assets: -8803000.00
URGN income_statement (annual, 2024-12-31) — Normalized EBITDA: -110335000.00
URGN income_statement (annual, 2024-12-31) — Normalized Income: -126874000.00
URGN cash_flow (annual, 2024-12-31) — Operating Cash Flow: -96766000.00
URGN cash_flow (annual, 2024-12-31) — Operating Gains Losses: 15077000.00
URGN income_statement (annual, 2024-12-31) — Operating Income: -96782000.00
URGN income_statement (annual, 2024-12-31) — Operating Revenue: 90398000.00
URGN balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 42231746.00
URGN balance_sheet (annual, 2024-12-31) — Other Current Assets: 8845000.00
URGN balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 7948000.00
URGN balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 56000.00
URGN income_statement (annual, 2024-12-31) — Other Income Expense: -229000.00
URGN balance_sheet (annual, 2024-12-31) — Other Inventories: -19000.00
URGN balance_sheet (quarterly, 2024-12-31) — Other Inventories: -19000.00
URGN cash_flow (annual, 2024-12-31) — Other Non Cash Items: -1305000.00
URGN balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 765000.00
URGN income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -229000.00
URGN balance_sheet (annual, 2024-12-31) — Other Properties: 4290000.00
URGN balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 64698000.00
URGN balance_sheet (annual, 2024-12-31) — Payables: 10931000.00
URGN balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 27431000.00
URGN balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 10570000.00
URGN income_statement (annual, 2024-12-31) — Pretax Income: -124042000.00
URGN cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 18962000.00
URGN balance_sheet (annual, 2024-12-31) — Properties: 0.00
URGN cash_flow (annual, 2024-12-31) — Purchase Of Investment: -128023000.00
URGN cash_flow (annual, 2024-12-31) — Purchase Of PPE: -295000.00
URGN balance_sheet (annual, 2024-12-31) — Raw Materials: 4724000.00
URGN balance_sheet (annual, 2024-12-31) — Receivables: 20302000.00
URGN income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 8881000.00
URGN income_statement (annual, 2024-12-31) — Reconciled Depreciation: 1186000.00
URGN cash_flow (annual, 2024-12-31) — Repayment Of Debt: 0.00
URGN income_statement (annual, 2024-12-31) — Research And Development: 57145000.00
URGN balance_sheet (annual, 2024-12-31) — Restricted Cash: 1076000.00
URGN balance_sheet (annual, 2024-12-31) — Retained Earnings: -806222000.00
URGN cash_flow (annual, 2024-12-31) — Sale Of Investment: 107705000.00
URGN income_statement (annual, 2024-12-31) — Selling General And Administration: 121154000.00
URGN balance_sheet (annual, 2024-12-31) — Share Issued: 42231746.00
URGN cash_flow (annual, 2024-12-31) — Stock Based Compensation: 13108000.00
URGN balance_sheet (annual, 2024-12-31) — Stockholders Equity: -8803000.00
URGN balance_sheet (annual, 2024-12-31) — Tangible Book Value: -8803000.00
URGN income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
URGN income_statement (annual, 2024-12-31) — Tax Provision: 2832000.00
URGN income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.21
URGN balance_sheet (annual, 2024-12-31) — Total Assets: 285711000.00
URGN balance_sheet (annual, 2024-12-31) — Total Capitalization: 112931000.00
URGN balance_sheet (annual, 2024-12-31) — Total Debt: 123387000.00
URGN balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: -8803000.00
URGN income_statement (annual, 2024-12-31) — Total Expenses: 187180000.00
URGN balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 294514000.00
URGN balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 9576000.00
URGN balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 248565000.00
URGN income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -96782000.00
URGN income_statement (annual, 2024-12-31) — Total Other Finance Cost: 23411000.00
URGN income_statement (annual, 2024-12-31) — Total Unusual Items: -23411000.00
URGN income_statement (quarterly, 2024-12-31) — Total Unusual Items: -6063000.00
URGN income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -23411000.00
URGN income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: -6063000.00
URGN balance_sheet (annual, 2024-12-31) — Tradeand Other Payables Non Current: 3791000.00
URGN balance_sheet (annual, 2024-12-31) — Working Capital: 230186000.00
URGN income_statement (quarterly, 2025-03-31) — +Operating Expense: 54838000.00
URGN income_statement (quarterly, 2025-03-31) — +Total Revenue: 20254000.00
URGN balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 14567000.00
URGN balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 19638000.00
URGN balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -4353000.00
URGN balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 803467000.00
URGN cash_flow (quarterly, 2025-03-31) — Amortization Of Securities: -774000.00
URGN balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 4514000.00
URGN income_statement (quarterly, 2025-03-31) — Basic Average Shares: 47422119.00
URGN income_statement (quarterly, 2025-03-31) — Basic EPS: -0.92
URGN cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 173062000.00
URGN cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -44000.00
URGN balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 2841000.00
URGN balance_sheet (quarterly, 2025-03-31) — Capital Stock: 126000.00
URGN balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 104033000.00
URGN balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 195890000.00
URGN cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 34000.00
URGN cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -25963000.00
URGN cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -42024000.00
URGN cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 2891000.00
URGN cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -3603000.00
URGN cash_flow (quarterly, 2025-03-31) — Change In Inventory: 1637000.00
URGN cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 218000.00
URGN cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -255000.00
URGN cash_flow (quarterly, 2025-03-31) — Change In Payable: 2891000.00
URGN cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -712000.00
URGN cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -4138000.00
URGN cash_flow (quarterly, 2025-03-31) — Change In Receivables: 664000.00
URGN cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -2586000.00
URGN cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 664000.00
URGN cash_flow (quarterly, 2025-03-31) — Changes In Cash: -67953000.00
URGN balance_sheet (quarterly, 2025-03-31) — Common Stock: 126000.00
URGN balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: -46458000.00
URGN cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 4000.00
URGN income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 2330000.00
URGN balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 15755000.00
URGN balance_sheet (quarterly, 2025-03-31) — Current Assets: 237177000.00
URGN balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 42000000.00
URGN cash_flow (quarterly, 2025-03-31) — Depreciation: 497000.00
URGN cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 497000.00
URGN cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 497000.00
URGN balance_sheet (quarterly, 2025-03-31) — Derivative Product Liabilities: 123336000.00
URGN income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 47422119.00
URGN income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.92
URGN income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -43843000.00
URGN income_statement (quarterly, 2025-03-31) — EBIT: -39383000.00
URGN income_statement (quarterly, 2025-03-31) — EBITDA: -38886000.00
URGN cash_flow (quarterly, 2025-03-31) — End Cash Position: 105109000.00
URGN cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 34000.00
URGN balance_sheet (quarterly, 2025-03-31) — Finished Goods: 3526000.00
URGN cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -42068000.00
URGN cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: -1889000.00
URGN income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -4583000.00
URGN balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 14000.00
URGN balance_sheet (quarterly, 2025-03-31) — Gross PPE: 9733000.00
URGN income_statement (quarterly, 2025-03-31) — Gross Profit: 17924000.00
URGN income_statement (quarterly, 2025-03-31) — Interest Expense: 4068000.00
URGN income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 4068000.00
URGN income_statement (quarterly, 2025-03-31) — Interest Income: 2204000.00
URGN income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 2204000.00
URGN balance_sheet (quarterly, 2025-03-31) — Inventory: 7590000.00
URGN balance_sheet (quarterly, 2025-03-31) — Invested Capital: 75650000.00
URGN cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -25963000.00
URGN balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 4514000.00
URGN balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 4514000.00
URGN cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 4000.00
URGN cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 0.00
URGN balance_sheet (quarterly, 2025-03-31) — Leases: 626000.00
URGN balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 2841000.00
URGN balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 122108000.00
URGN balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 124949000.00
URGN cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 0.00
URGN cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: 0.00
URGN balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 3195000.00
URGN cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 4000.00
URGN balance_sheet (quarterly, 2025-03-31) — Net Debt: 18075000.00
URGN income_statement (quarterly, 2025-03-31) — Net Income: -43843000.00
URGN income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -43843000.00
URGN income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -43843000.00
URGN income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -43843000.00
URGN income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -43843000.00
URGN cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -43843000.00
URGN income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -43843000.00
URGN income_statement (quarterly, 2025-03-31) — Net Interest Income: -6447000.00
URGN cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: -25919000.00
URGN cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 0.00
URGN cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 0.00
URGN income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -6447000.00
URGN balance_sheet (quarterly, 2025-03-31) — Net PPE: 5380000.00
URGN cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -44000.00
URGN balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -46458000.00
URGN income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -38886000.00
URGN income_statement (quarterly, 2025-03-31) — Normalized Income: -43843000.00
URGN cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -42024000.00
URGN cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -1889000.00
URGN income_statement (quarterly, 2025-03-31) — Operating Income: -36914000.00
URGN income_statement (quarterly, 2025-03-31) — Operating Revenue: 20254000.00
URGN balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 46101785.00
URGN balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 12983000.00
URGN balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 4711000.00
URGN balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 14000.00
URGN income_statement (quarterly, 2025-03-31) — Other Income Expense: -90000.00
URGN cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 3502000.00
URGN balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 547000.00
URGN income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -90000.00
URGN balance_sheet (quarterly, 2025-03-31) — Other Properties: 5912000.00
URGN balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 91857000.00
URGN balance_sheet (quarterly, 2025-03-31) — Payables: 14567000.00
URGN balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 30322000.00
URGN balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 6967000.00
URGN income_statement (quarterly, 2025-03-31) — Pretax Income: -43451000.00
URGN cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 30000.00
URGN balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
URGN cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -66351000.00
URGN cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -44000.00
URGN balance_sheet (quarterly, 2025-03-31) — Raw Materials: 4064000.00
URGN balance_sheet (quarterly, 2025-03-31) — Receivables: 19638000.00
URGN income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 2330000.00
URGN income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 497000.00
URGN cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: 0.00
URGN income_statement (quarterly, 2025-03-31) — Research And Development: 19871000.00
URGN balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 1076000.00
URGN balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -850065000.00
URGN cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 40432000.00
URGN income_statement (quarterly, 2025-03-31) — Selling General And Administration: 34967000.00
URGN balance_sheet (quarterly, 2025-03-31) — Share Issued: 46101785.00
URGN cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 3069000.00
URGN balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: -46458000.00
URGN balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -46458000.00
URGN income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
URGN income_statement (quarterly, 2025-03-31) — Tax Provision: 392000.00
URGN income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.21
URGN balance_sheet (quarterly, 2025-03-31) — Total Assets: 247618000.00
URGN balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 75650000.00
URGN balance_sheet (quarterly, 2025-03-31) — Total Debt: 124949000.00
URGN balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: -46458000.00
URGN income_statement (quarterly, 2025-03-31) — Total Expenses: 57168000.00
URGN balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 294076000.00
URGN balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 10441000.00
URGN balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 252076000.00
URGN income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -36914000.00
URGN income_statement (quarterly, 2025-03-31) — Total Other Finance Cost: 4583000.00
URGN income_statement (quarterly, 2025-03-31) — Total Unusual Items: -4583000.00
URGN income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -4583000.00
URGN balance_sheet (quarterly, 2025-03-31) — Tradeand Other Payables Non Current: 3791000.00
URGN balance_sheet (quarterly, 2025-03-31) — Working Capital: 195177000.00
URGN income_statement (quarterly, 2025-06-30) — +Operating Expense: 62113000.00
URGN income_statement (quarterly, 2025-06-30) — +Total Revenue: 24215000.00
URGN balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 13564000.00
URGN balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 19649000.00
URGN balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -4433000.00
URGN balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 806497000.00
URGN cash_flow (quarterly, 2025-06-30) — Amortization Of Securities: -866000.00
URGN balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 4632000.00
URGN income_statement (quarterly, 2025-06-30) — Basic Average Shares: 47739816.00
URGN income_statement (quarterly, 2025-06-30) — Basic EPS: -1.05
URGN cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 105109000.00
URGN cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -141000.00
URGN balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 3413000.00
URGN balance_sheet (quarterly, 2025-06-30) — Capital Stock: 126000.00
URGN balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 92904000.00
URGN balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 156954000.00
URGN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 296000.00
URGN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 28406000.00
URGN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -39825000.00
URGN cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 640000.00
URGN cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 4679000.00
URGN cash_flow (quarterly, 2025-06-30) — Change In Inventory: 462000.00
URGN cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: -430000.00
URGN cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -1027000.00
URGN cash_flow (quarterly, 2025-06-30) — Change In Payable: 640000.00
URGN cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 5319000.00
URGN cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 928000.00
URGN cash_flow (quarterly, 2025-06-30) — Change In Receivables: -11000.00
URGN cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 5240000.00
URGN cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -11000.00
URGN cash_flow (quarterly, 2025-06-30) — Changes In Cash: -11123000.00
URGN balance_sheet (quarterly, 2025-06-30) — Common Stock: 126000.00
URGN balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: -93376000.00
URGN cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: -4000.00
URGN income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 3550000.00
URGN balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 17398000.00
URGN balance_sheet (quarterly, 2025-06-30) — Current Assets: 196868000.00
URGN balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 47548000.00
URGN cash_flow (quarterly, 2025-06-30) — Depreciation: 596000.00
URGN cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 596000.00
URGN cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 596000.00
URGN balance_sheet (quarterly, 2025-06-30) — Derivative Product Liabilities: 124833000.00
URGN income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 47739816.00
URGN income_statement (quarterly, 2025-06-30) — Diluted EPS: -1.05
URGN income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -49940000.00
URGN income_statement (quarterly, 2025-06-30) — EBIT: -44793000.00
URGN income_statement (quarterly, 2025-06-30) — EBITDA: -44197000.00
URGN cash_flow (quarterly, 2025-06-30) — End Cash Position: 93986000.00
URGN cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 296000.00
URGN balance_sheet (quarterly, 2025-06-30) — Finished Goods: 3807000.00
URGN cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -39966000.00
URGN cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: 2012000.00
URGN income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: -4644000.00
URGN balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 6000.00
URGN balance_sheet (quarterly, 2025-06-30) — Gross PPE: 10672000.00
URGN income_statement (quarterly, 2025-06-30) — Gross Profit: 20665000.00
URGN income_statement (quarterly, 2025-06-30) — Interest Expense: 4132000.00
URGN income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 4132000.00
URGN income_statement (quarterly, 2025-06-30) — Interest Income: 1677000.00
URGN income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 1677000.00
URGN balance_sheet (quarterly, 2025-06-30) — Inventory: 7128000.00
URGN balance_sheet (quarterly, 2025-06-30) — Invested Capital: 29132000.00
URGN cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 28406000.00
URGN balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 4632000.00
URGN balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 4632000.00
URGN cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: -4000.00
URGN balance_sheet (quarterly, 2025-06-30) — Leases: 626000.00
URGN balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 3413000.00
URGN balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 122508000.00
URGN balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 125921000.00
URGN balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 3336000.00
URGN cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -4000.00
URGN balance_sheet (quarterly, 2025-06-30) — Net Debt: 29604000.00
URGN income_statement (quarterly, 2025-06-30) — Net Income: -49940000.00
URGN income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -49940000.00
URGN income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -49940000.00
URGN income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -49940000.00
URGN income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -49940000.00
URGN cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -49940000.00
URGN income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -49940000.00
URGN income_statement (quarterly, 2025-06-30) — Net Interest Income: -7099000.00
URGN cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 28547000.00
URGN income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -7099000.00
URGN balance_sheet (quarterly, 2025-06-30) — Net PPE: 6239000.00
URGN cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -141000.00
URGN balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -93376000.00
URGN income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -44197000.00
URGN income_statement (quarterly, 2025-06-30) — Normalized Income: -49940000.00
URGN cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -39825000.00
URGN cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 2012000.00
URGN income_statement (quarterly, 2025-06-30) — Operating Income: -41448000.00
URGN income_statement (quarterly, 2025-06-30) — Operating Revenue: 24215000.00
URGN balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 46199134.00
URGN balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 12055000.00
URGN balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 4940000.00
URGN balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 6000.00
URGN income_statement (quarterly, 2025-06-30) — Other Income Expense: -378000.00
URGN balance_sheet (quarterly, 2025-06-30) — Other Inventories: -432000.00
URGN cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 400000.00
URGN balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 978000.00
URGN income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: -378000.00
URGN balance_sheet (quarterly, 2025-06-30) — Other Properties: 6710000.00
URGN balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 64050000.00
URGN balance_sheet (quarterly, 2025-06-30) — Payables: 13564000.00
URGN balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 30962000.00
URGN balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 11646000.00
URGN income_statement (quarterly, 2025-06-30) — Pretax Income: -48925000.00
URGN cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 300000.00
URGN balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
URGN cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -1789000.00
URGN cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -141000.00
URGN balance_sheet (quarterly, 2025-06-30) — Raw Materials: 3753000.00
URGN balance_sheet (quarterly, 2025-06-30) — Receivables: 19649000.00
URGN income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 3550000.00
URGN income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 596000.00
URGN income_statement (quarterly, 2025-06-30) — Research And Development: 18914000.00
URGN balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 1082000.00
URGN balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -900005000.00
URGN cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 30336000.00
URGN income_statement (quarterly, 2025-06-30) — Selling General And Administration: 43199000.00
URGN balance_sheet (quarterly, 2025-06-30) — Share Issued: 46199134.00
URGN cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 2733000.00
URGN balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: -93376000.00
URGN balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -93376000.00
URGN income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
URGN income_statement (quarterly, 2025-06-30) — Tax Provision: 1015000.00
URGN income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
URGN balance_sheet (quarterly, 2025-06-30) — Total Assets: 208717000.00
URGN balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 29132000.00
URGN balance_sheet (quarterly, 2025-06-30) — Total Debt: 125921000.00
URGN balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: -93376000.00
URGN income_statement (quarterly, 2025-06-30) — Total Expenses: 65663000.00
URGN balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 302093000.00
URGN balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 11849000.00
URGN balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 254545000.00
URGN income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -41448000.00
URGN income_statement (quarterly, 2025-06-30) — Total Other Finance Cost: 4644000.00
URGN income_statement (quarterly, 2025-06-30) — Total Unusual Items: -4644000.00
URGN income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -4644000.00
URGN balance_sheet (quarterly, 2025-06-30) — Tradeand Other Payables Non Current: 3791000.00
URGN balance_sheet (quarterly, 2025-06-30) — Working Capital: 149320000.00
URGN income_statement (quarterly, 2025-09-30) — +Operating Expense: 51590000.00
URGN income_statement (quarterly, 2025-09-30) — +Total Revenue: 27482000.00
URGN balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 10279000.00
URGN balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 19703000.00
URGN balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -4513000.00
URGN balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 817793000.00
URGN cash_flow (quarterly, 2025-09-30) — Amortization Of Securities: -160000.00
URGN balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 380000.00
URGN income_statement (quarterly, 2025-09-30) — Basic Average Shares: 48057386.00
URGN income_statement (quarterly, 2025-09-30) — Basic EPS: -0.69
URGN cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 93986000.00
URGN cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -87000.00
URGN balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 6241000.00
URGN balance_sheet (quarterly, 2025-09-30) — Capital Stock: 128000.00
URGN balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 90039000.00
URGN balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 127033000.00
URGN cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 8272000.00
URGN cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 31398000.00
URGN cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -42270000.00
URGN cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -4789000.00
URGN cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: -532000.00
URGN cash_flow (quarterly, 2025-09-30) — Change In Inventory: -1213000.00
URGN cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: -5958000.00
URGN cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -891000.00
URGN cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 0.00
URGN cash_flow (quarterly, 2025-09-30) — Change In Payable: -4789000.00
URGN cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -5321000.00
URGN cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -67000.00
URGN cash_flow (quarterly, 2025-09-30) — Change In Receivables: -54000.00
URGN cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -13504000.00
URGN cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -54000.00
URGN cash_flow (quarterly, 2025-09-30) — Changes In Cash: -2600000.00
URGN balance_sheet (quarterly, 2025-09-30) — Common Stock: 128000.00
URGN balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: -115408000.00
URGN cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 7970000.00
URGN income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 3278000.00
URGN balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 15894000.00
URGN balance_sheet (quarterly, 2025-09-30) — Current Assets: 168546000.00
URGN balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 42244000.00
URGN cash_flow (quarterly, 2025-09-30) — Depreciation: 639000.00
URGN cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 639000.00
URGN cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 639000.00
URGN balance_sheet (quarterly, 2025-09-30) — Derivative Product Liabilities: 126067000.00
URGN income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 48057386.00
URGN income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.69
URGN income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -33347000.00
URGN income_statement (quarterly, 2025-09-30) — EBIT: -31028000.00
URGN income_statement (quarterly, 2025-09-30) — EBITDA: -30389000.00
URGN cash_flow (quarterly, 2025-09-30) — End Cash Position: 91386000.00
URGN cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 8272000.00
URGN balance_sheet (quarterly, 2025-09-30) — Finished Goods: 3582000.00
URGN cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -42357000.00
URGN cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: 1472000.00
URGN income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: -4621000.00
URGN balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 23000.00
URGN balance_sheet (quarterly, 2025-09-30) — Gross PPE: 13697000.00
URGN income_statement (quarterly, 2025-09-30) — Gross Profit: 24204000.00
URGN income_statement (quarterly, 2025-09-30) — Interest Expense: 3373000.00
URGN income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 3373000.00
URGN income_statement (quarterly, 2025-09-30) — Interest Income: 1176000.00
URGN income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 1176000.00
URGN balance_sheet (quarterly, 2025-09-30) — Inventory: 8341000.00
URGN balance_sheet (quarterly, 2025-09-30) — Invested Capital: 6703000.00
URGN cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 31398000.00
URGN balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 380000.00
URGN balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 380000.00
URGN cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 7970000.00
URGN balance_sheet (quarterly, 2025-09-30) — Leases: 626000.00
URGN balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 6241000.00
URGN balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 122111000.00
URGN balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 128352000.00
URGN balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 3395000.00
URGN cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 7970000.00
URGN balance_sheet (quarterly, 2025-09-30) — Net Debt: 32072000.00
URGN income_statement (quarterly, 2025-09-30) — Net Income: -33347000.00
URGN income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -33347000.00
URGN income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -33347000.00
URGN income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -33347000.00
URGN income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -33347000.00
URGN cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -33347000.00
URGN income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -33347000.00